SMS Pharmaceuticals shows strong profit growth

SMS Pharmaceuticals Limited

reported a sharp improvement in Q1 FY27 profitability, but the revenue growth story remains more moderate. The stock was around ₹471 on October 1, close to its recent highs. What happened Q1 FY27 revenue increased 5.6% year on year to ₹206.96 crore. Operating profit rose 4.5% to ₹30.96 crore, while profit after tax increased 2.0% to ₹20.91 crore. Operating margin was 14.96%. **Why the next quarter matters** The more interesting signal is the September quarter. The available quarterly data shows revenue at ₹242.43 crore, up 23.2% year on year, while operating income rose 67.9% year on year to ₹38.34 crore. Net profit increased 79.5% to ₹25.31 crore. That is a much stronger sequential picture than Q1 and suggests operating leverage may be improving. **My view** I would not judge SMS Pharma only on the Q1 number. The improvement visible in the September-quarter data is more encouraging. However, the stock has already moved close to its recent high, so the next question is whether higher revenue can sustain margins and cash generation. **What I am watching** Revenue growth, operating margin, export performance and whether the September-quarter profitability improvement continues into the second half of FY27. **Stance:** Positive on the earnings trend, but I would wait for confirmation that the margin improvement is sustainable. Disclosure: I do not hold a position in SMS Pharmaceuticals Limited. Not investment advice.